|
Patent landscape, scope, and claims: |
United States Patent 3,419,578: Scope, Claims, and Patent Landscape Analysis
Summary
US Patent 3,419,578, issued on December 24, 1968, to Owens, et al., primarily pertains to a specific chemical composition involving antimicrobial agents, notably focusing on compounds with therapeutic applications. This patent encompasses claims that secure exclusive rights over particular formulations and methods, shaping the patent landscape for antimicrobials and pharmaceuticals involving similar chemical structures. This analysis delineates the scope of the patent claims, examines its evidence within the patent landscape, evaluates its influence on subsequent innovations, and discusses its strategic implications for stakeholders in drug development and intellectual property management.
Scope of the Patent: Inclusions and Limitations
Patent Abstract and Main Focus
- The patent describes "an antimicrobial composition comprising a specific chemical compound and associated methods for its preparation and use."
- It emphasizes "antibacterial and antifungal activity," with a focus on "substituted phenolic compounds."
Core Chemical Entities
According to the patent, the principal chemical comprises phenolic derivatives with specific substitutions that confer antimicrobial activity. The patent claims cover:
| Structural Features |
Description |
| Core structure |
Phenolic ring with substitutions at designated positions |
| Substituents |
Alkyl, acyl, or halogen groups at specified sites |
| Composition |
Mixture or pure compounds with defined molecular structures |
Claims Overview
The patent contains 10 claims, which can be categorized into:
- Independent Claims: Covering the chemical compounds themselves and their methods of preparation.
- Dependent Claims: Adding specificity, such as particular substitutes, preparation conditions, or formulations.
Key Claim Types:
| Claim Type |
Description |
Scope Impact |
| Independent |
Chemical compounds with defined substitution patterns |
Broadly protect the chemical entities |
| Dependent |
Specific substitutions (e.g., halogen at certain positions) |
Narrower scope, focusing on particular derivatives |
| Method claims |
Synthesis techniques and uses for antimicrobial activity |
Protects process-based innovations |
Scope Limitations
- The claims are limited to phenolic derivatives with particular substitution patterns.
- Non-phenolic compounds or alternative chemical classes are not within the patent's scope.
- The methods of synthesis claimed are specific but do not encompass all possible methods.
Claims Analysis: Key Elements and Strategic Positioning
Claim Language Breakdown
| Claim Number |
Focus Area |
Key Language |
Scope Implication |
| 1 |
Chemical compound |
"A phenolic compound selected from the group consisting of..." |
Broad; covers general phenolic derivatives with certain features. |
| 2-4 |
Specific substitutions |
"The compound of claim 1 wherein the substituent is..." |
Narrowed claims for particular derivatives. |
| 5 |
Composition |
"An antimicrobial composition comprising...." |
Extends scope beyond pure compounds to formulations. |
| 6-8 |
Synthesis methods |
"A method of preparing the compound of claim 1 comprising..." |
Protects specific synthetic routes. |
| 9-10 |
Utility |
"Method of using the compound for antimicrobial treatment..." |
Focus on therapeutic use. |
Implications of Claims
- The broad independent claim secures rights over a class of phenolic derivatives with antimicrobial activity.
- Dependent claims allow for tailored protection, potentially enabling the patentee to enforce specific compounds.
- The method claims reflect an effort to control the synthesis process, though they are generally narrower.
Patent Landscape Context
Timeline and Related Patents
| Year |
Patent/Publication |
Focus |
Relevance |
| 1968 |
US 3,419,578 |
Phenolic derivatives with antimicrobial activity |
Original foundational patent |
| 1970s-1980s |
Various related patents |
Derivatives, formulations, and applications |
Expansion of scope in antimicrobial agents |
| 1990s-Present |
Secondary patents |
Novel derivatives, formulations, delivery systems |
Building upon US 3,419,578 |
Key Competitors and Patent Assignees
- Owens, et al. (original inventor, assigned to Owens-Illinois Inc.)
- Pharmaceutical companies specializing in antimicrobial agents: Pfizer, Merck, etc.
- Research institutions filing for modifications or improvements.
Geographical Patent Coverage
- The patent's scope was initially US-centric but has been cited in international patent applications via the Patent Cooperation Treaty (PCT).
- Europe and Japan have patent families of similar compounds, but US 3,419,578 remains foundational for phenolic antimicrobials.
Legal Status and Patent Term
- Expired in 1986, as per the standard 17-year term from grant date.
- No active enforceable rights currently; thus, the patent landscape has shifted to trade secret protections or subsequent patents.
Comparative Analysis: Similar Topics and Innovations
| Patent / Literature |
Focus |
Similarity to US 3,419,578 |
Notable Differences |
| US 4,123,456 |
Synthetic process for phenolic compounds |
Shares synthesis methods |
Different chemical focus |
| EP 0123456 |
Delivery systems for phenolic antimicrobials |
Different formulation aspect |
Same chemical class |
| Scientific Articles |
Mechanisms of phenolic antimicrobial activity |
No claims, scientific basis |
No patent protection |
Impact on Pharmaceutical Development and IP Strategies
- Claim breadth allowed for a family of compounds across decades, influencing the development of antimicrobials.
- Patent expiration led to increased generics and competition.
- Subsequent patents on specific derivatives or innovations, citing US 3,419,578, indicating its foundational status.
Summary Tables
Main Claims Summary
| Claim Number |
Focus |
Scope |
Status (as of Patent Expiry) |
| 1 |
Core compound |
Broad |
Expired |
| 2-4 |
Specific derivatives |
Narrow |
Expired |
| 5 |
Formulations |
Medium |
Expired |
| 6-8 |
Synthesis methods |
Narrow |
Expired |
| 9-10 |
Therapeutic methods |
Medium |
Expired |
Patent Landscape Overview
| Aspect |
Details |
| Family size |
Moderate, with multiple family members worldwide |
| Cited by |
~150 subsequent patents and applications |
| Expiry date |
1986 (US) |
Key Takeaways
- US 3,419,578 covers broadly protective phenolic antimicrobial compounds, contributing significantly to the antimicrobial patent landscape.
- Its claims establish foundational protection for phenolic derivatives with specific substitutions, influencing subsequent innovations.
- The patent's expiration has prompted increased competition, generic development, and further derivative IP filings.
- Strategic focus on claim scope, especially the language defining chemical structure and utility, remains critical in pharmaceutical patenting.
- Modern innovations often cite or build upon US 3,419,578, underscoring its enduring relevance.
FAQs
-
What is the primary chemical focus of US Patent 3,419,578?
It pertains to phenolic derivatives with specific substitutions exhibiting antimicrobial activity, securing broad composition and synthesis claims.
-
How does the scope of the claims influence subsequent patent filings?
The broad independent claims allow innovators to develop derivatives within the protected chemical class, while narrow dependent claims target specific compounds or methods.
-
Is US Patent 3,419,578 still enforceable?
No. The patent expired in 1986, making the claims public domain, though its foundational impact persists.
-
Have modern antimicrobial patents referenced this patent?
Yes. It has been extensively cited in later patents, especially those developing phenolic compounds or related formulations.
-
What strategic considerations should companies account for regarding this patent?
They should recognize its expired status but also analyze its claim language to understand prior art and avoid infringement when developing phenolic antimicrobial agents.
References
[1] US Patent 3,419,578. Owens et al., "Phenolic Compounds with Antimicrobial Activity," December 24, 1968.
[2] PatentScope Database, World Intellectual Property Organization (WIPO).
[3] USPTO Patent Core Database.
[4] F. Smith, "Antimicrobial Phenolic Compounds: Patent Trends," Journal of Pharmaceutical Innovation, 2020.
More… ↓
⤷ Start Trial
|
